Antiphospholipid antibodies: guidelines for determination.

J Clin Rheumatol

Systemic Autoimmune Diseases Unit, Hospital Clinic, Barcelona, Catalonia, Spain, and Rheumatic Diseases Unit, Department of Medicine, University of Cape Town School of Medicine, Cape Town, South Africa.

Published: December 1997

AI Article Synopsis

  • The article highlights the need for clearer guidelines on when to test for antiphospholipid antibodies (aPL) and which laboratory tests to use, as there are still uncertainties in clinical practice.
  • It reviews key clinical situations warranting aPL testing, such as systemic lupus erythematosus, various autoimmune disorders, and cases of thrombosis or recurrent fetal losses.
  • Additionally, it proposes a comprehensive evaluation for patients showing symptoms of aPL syndrome who test negative for aPL in standard tests, known as "seronegative" aPL syndrome.

Article Abstract

Although significant progress has been made during the last decade in our knowledge of the antiphospholipid antibodies (aPL), there are two major questions in clinical practice that require further guidelines: Indications for aPL determination and laboratory tests to choose. This article reviews the main clinical indications to search for aPL (systemic lupus erythematosus, selected autoimmune conditions, spontaneous venous and arterial thrombosis, recurrent fetal losses, and autoimmune thrombocytopenia, among others) as well as the routine tests to detect aPL (serological tests for syphilis, lupus anticoagulant tests, solid phase techniques to detect anticardiolipin and other aPL and antibodies to aPL cofactors). Finally, a complete work-up is suggested for those patients with clinical manifestations of the aPL syndrome but without detection of aPL in the routine tests ("seronegative" aPL syndrome).

Download full-text PDF

Source

Publication Analysis

Top Keywords

apl
9
antiphospholipid antibodies
8
antibodies apl
8
routine tests
8
apl syndrome
8
tests
5
antibodies guidelines
4
guidelines determination
4
determination progress
4
progress decade
4

Similar Publications

Background: Accurate donor-recipient matching of the femoral condyle radius of curvature (ROC) in osteochondral allograft (OCA) transplantation may aid in minimizing articular surface incongruities. Matching linear femorotibial dimensions, such as the femoral condyle anterior-posterior length (APL), femoral condyle width (lateral-medial length, LML), femoral hemicondyle width (HCW), and tibial plateau width (TPW), can provide similar results if they correlate well with ROC. This study investigates the relationship between femorotibial dimensions and ROC at the cartilage surface using magnetic resonance imaging (MRI).

View Article and Find Full Text PDF

Background: Trapeziectomy and abductor pollicis longus hammock ligamentoplasty may be performed in the surgical management of trapeziometacarpal joint osteoarthritis (TMC OA). Several anaesthesia techniques are available for TMC joint surgery, including wide-awake local anaesthesia no tourniquet (WALANT), regional anaesthesia, and general anaesthesia (GA). The aim of this study was to compare the clinical outcomes of trapeziectomy and abductor pollicis longus hammock ligamentoplasty performed under WALANT versus GA.

View Article and Find Full Text PDF

The prognosis for patients with acute promyelocytic leukemia (APL) has improved dramatically since the introduction of all-trans retinoic acid (ATRA) and intravenous arsenic trioxide (ATO). However, ATO administration requires daily infusions over several months, representing an onerous burden for hospitals and patients. We evaluated the bioavailability of a novel encapsulated oral ATO formulation in APL patients in first complete remission during standard-of-care consolidation.

View Article and Find Full Text PDF

Background: Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is a health insurance scheme launched by the Government of India (GOI) in 2018 to cover the in-patient (IP) treatment expenditures, including mental illness treatment expenditures, for 500 million Indians. AB-PMJAY pays 100% of treatment expenditures for persons below the poverty line (BPL) and 30% for people above the poverty line (APL). Ayushman Bharat Arogya Karnataka (ABAK) trust implements this scheme in Karnataka, a southern Indian state.

View Article and Find Full Text PDF

An obstacle for many microfluidic developments is the fabrication of its structures, which is often complex, time-consuming, and expensive. Additive manufacturing can help to reduce these barriers. This study investigated whether the results of a microfluidic assay for the detection of the promyelocytic leukemia (PML)-retinoic acid receptor α (RARα) fusion protein (PML::RARA), and thus for the differential diagnosis of acute promyelocytic leukemia (APL), could be transferred from borosilicate glass microfluidic structures to additively manufactured fluidics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!